Sanya has more than 20 years of experience litigating life sciences patent disputes, including Hatch-Waxman abbreviated new drug application (ANDA) challenges for brand drug manufacturers, biological products and medical devices. Drawing from extensive litigation experience, Sanya also advises clients on an array of pre-litigation and acquisition due diligence investigations, as well as strategic patent portfolio planning.

Download full bio 


  • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 

[Sanya] has great vision and a disarming personality – as opposing counsel, you might not notice what ‘litigation thing’ he is doing to you. – Intellectual Asset Management Patent 1000

  • Washington College of Law American University
    JD, cum laude, 1999

  • Boston College
    BS, Biology

Admissions & Credentials

District of Columbia


U.S. Patent and Trademark Office


  • American Intellectual Property Law Association

  • National Asian Pacific American Bar Association

  • Thai American Bar Association

Rankings & Accolades

    LMG Life Sciences: Shortlisted for General Patent Litigator of the Year – DC Metro (2016, 2017, 2021)

    The Legal 500 US: Healthcare: Life Sciences (2021)

    The Legal 500 US: Patents: Litigation (2021)

    IAM Media: IAM Patent 1000 List for Patent Litigation (2018 – 2020)

    LMG Life Sciences: Life Science Star – Intellectual Property (2012 – 2021)

    Managing Intellectual Property: Shortlisted for Outstanding Litigator: District of Columbia (2017)

    Managing Intellectual Property: IP Star (2022)

    National Asian Pacific American Bar Association: Best Lawyers Under 40 (2013)

    Eli Lilly and Company: Quality Advocate Award (2011)